Laznicka, A., Curik, N., Krizkova, J., Rajnisova, K., Suchankova, P., Stefikova, B., Zhuk, K., Polivkova, V., Pokorna, E., Klener, P., Salek, C., Klamova, H., Ransdorfova, S., Hochhaus, A., Polakova, K. M. (2025). Ponatinib-based combination therapies including asciminib and venetoclax were effective on patient-derived xenograft models of chronic myeloid leukemia in blast Phase. Blood. https://doi.org/10.1182/blood-2025-3284